Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Middle East Respiratory Syndrome (MERS)
June 7, 2013
To date, little is known about pathogenic potential and transmission dynamics of Middle East Respiratory Syndrome Coronavirus (MERS -CoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain MERS-CoV.
Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible MERS-CoV infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling.
General and specific biosafety guidelines for handling MERS-CoV specimens are provided below.